Danazol

达那唑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDanazol
Drug Alias Name炔羟雄烯唑Danazolum丹哪唑丹那唑安宫唑 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsRejection of lung transplantationDiabetic macular oedemaTelomere Shortening +[19] 
Global Approved IndicationsPuberty, PrecociousGynecomastiaFibrocystic Breast Disease +[7] 
Approved Indications in ChinaPuberty, PrecociousGynecomastiaFibrocystic Breast Disease +[7] 
Original Approved Country/TerritoryUnited States
Original Approved Date1976/06/21
Country/TerritoryCanadaUnited StatesRussian Federation +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Southern CaliforniaJiangsu Lianhuan Pharmaceutical Co Ltd
Inactive CompaniesLumara Health IncThe Brigham and Women's HospitalThe University Of Queensland +[10] 
Active IndicationsCytopeniaPuberty, PrecociousGynecomastia +[9] 
Inactive IndicationsRejection of lung transplantationDiabetic macular oedemaTelomere Shortening +[10] 

Other Information

ATC CodeG03XA01
Related LinksWikipediaDrugBankKEGG